Cytokinetics Statistics

Total Valuation

Cytokinetics has a market cap or net worth of $8.03 billion. The enterprise value is $8.42 billion.

Market Cap	8.03B
Enterprise Value	8.42B

Important Dates

The last earnings date was Wednesday, November 5, 2025, after market close.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	n/a

Share Statistics

Cytokinetics has 122.26 million shares outstanding. The number of shares has increased by 11.00% in one year.

Current Share Class	122.26M
Shares Outstanding	122.26M
Shares Change (YoY)	+11.00%
Shares Change (QoQ)	+0.44%
Owned by Insiders (%)	0.39%
Owned by Institutions (%)	116.94%
Float	121.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	89.62
Forward PS	66.87
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	96.51
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.88

Current Ratio	6.88
Quick Ratio	6.78
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.96

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-24.93%
Return on Invested Capital (ROIC)	-41.55%
Return on Capital Employed (ROCE)	-44.26%
Revenue Per Employee	$175,122
Profits Per Employee	-$1.51M
Employee Count	498
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +30.19% in the last 52 weeks. The beta is 0.59, so Cytokinetics's price volatility has been lower than the market average.

Beta (5Y)	0.59
52-Week Price Change	+30.19%
50-Day Moving Average	61.57
200-Day Moving Average	44.58
Relative Strength Index (RSI)	54.74
Average Volume (20 Days)	1,875,434

Short Selling Information

The latest short interest is 14.38 million, so 11.76% of the outstanding shares have been sold short.

Short Interest	14.38M
Short Previous Month	13.79M
Short % of Shares Out	11.76%
Short % of Float	11.81%
Short Ratio (days to cover)	7.75

Income Statement

In the last 12 months, Cytokinetics had revenue of $87.21 million and -$751.94 million in losses. Loss per share was -$6.32.

Revenue	87.21M
Gross Profit	-318.05M
Operating Income	-572.93M
Pretax Income	-751.94M
Net Income	-751.94M
EBITDA	-563.29M
EBIT	-572.93M
Loss Per Share	-$6.32

Full Income Statement

Balance Sheet

The company has $962.54 million in cash and $1.35 billion in debt, giving a net cash position of -$387.72 million or -$3.17 per share.

Cash & Cash Equivalents	962.54M
Total Debt	1.35B
Net Cash	-387.72M
Net Cash Per Share	-$3.17
Equity (Book Value)	-521.12M
Book Value Per Share	-4.26
Working Capital	835.21M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$432.93 million and capital expenditures -$20.45 million, giving a free cash flow of -$453.38 million.

Operating Cash Flow	-432.93M
Capital Expenditures	-20.45M
Free Cash Flow	-453.38M
FCF Per Share	-$3.71

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-656.95%
Pretax Margin	-862.21%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Cytokinetics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.00%
Shareholder Yield	-11.00%
Earnings Yield	-9.37%
FCF Yield	-5.65%

Dividend Details

Analyst Forecast

The average price target for Cytokinetics is $77.87, which is 18.58% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$77.87
Price Target Difference	18.58%
Analyst Consensus	Strong Buy
Analyst Count	15
Revenue Growth Forecast (5Y)	121.45%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on June 25, 2013. It was a reverse split with a ratio of 1:6.

Last Split Date	Jun 25, 2013
Split Type	Reverse
Split Ratio	1:6

Scores

Cytokinetics has an Altman Z-Score of -2.2 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.2
Piotroski F-Score	3